Journal of Neuroendovascular Therapy
Online ISSN : 2186-2494
Print ISSN : 1882-4072
ISSN-L : 1882-4072

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Endovascular Therapy for Acute Stroke: New Evidence and Indications
Anurag SahooMohamad AbdalkaderHiroshi YamagamiXiaochuan HuoDapeng SunBaixue JiaCharlotte S. WeylandFrancesco DianaArtem KaliaevPiers KleinJenny BuiSami Al KasabAdam de HavenonOsama O. ZaidatWenjie ZiQingwu YangPatrik MichelJames E. SieglerShadi YaghiWei HuThanh N. Nguyen
著者情報
ジャーナル オープンアクセス 早期公開

論文ID: ra.2023-0047

この記事には本公開記事があります。
詳細
抄録

Endovascular therapy (EVT) has revolutionized the treatment of acute ischemic stroke. In the past few years, endovascular treatment indications have expanded to include patients being treated in the extended window, with large ischemic core infarction, basilar artery occlusion (BAO) thrombectomy, as demonstrated by several randomized clinical trials. Intravenous thrombolysis (IVT) bridging to mechanical thrombectomy has also been studied via several randomized clinical trials, with the overall results indicating that IVT should not be skipped in patients who are candidates for both IVT and EVT. Simplification of neuroimaging protocols in the extended window to permit non-contrast CT, CTA collaterals have also expanded access to mechanical thrombectomy, particularly in regions across the world where access to advanced imaging may not be available. Ongoing study of areas to develop include rescue stenting in patients with failed thrombectomy, medium vessel occlusion thrombectomy, and carotid tandem occlusions. In this narrative review, we summarize recent trials and key data in the treatment of patients with large ischemic core infarct, simplification of neuroimaging protocols for the treatment of patients presenting in the late window, bridging thrombolysis, and BAO EVT evidence. We also summarize areas of ongoing study including medium and distal vessel occlusion.

著者関連情報
© 2023 The Japanese Society for Neuroendovascular Therapy

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
feedback
Top